Yearly Archives: "2019"

Billings Clinic hosts its first multiple sclerosis health and well-being symposium
The Billings Clinic hosted its first Multiple Sclerosis Health and Well-Being Symposium. It was a day-long educational seminar for people [...]
In memoriam: Dr. Conomy, a founder and former Executive Director of the CMSC
John “Jack” Paul Conomy died peacefully on June 9, 2019 at his home in Chagrin Falls, Ohio. A proud Cleveland native, Jack [...]
Lenox Hill Hospital multiple sclerosis support group
Encouragement and Empowerment for People With MS. Living with MS has its challenges, but you don’t have to face them alone.  Lead [...]
Study moves closer to identifying cause of multiple sclerosis
A study by the University of British Columbia made a scientific advance that researchers hope will lead to the development of preventative [...]
More About MS (2019)
In this program, people living with or affected by MS will have the opportunity to network with one another and to learn from leading MS [...]
UCLA researchers work to advance treatment targeting source of multiple sclerosis
UCLA researchers are developing the first multiple sclerosis treatment that could target the cause of the disease, instead of simply [...]
Genentech presenting new Ocrevus (Ocrelizumab) data at AAN Meeting
Genentech to Present New OCREVUS (ocrelizumab) Data Analyses Showing Significant Reduction of Disability Progression in Relapsing and [...]
MSAA recognizes ten years of artwork from individuals with multiple sclerosis
CHERRY HILL, N.J., May 2, 2019 /PRNewswire/ -- The Multiple Sclerosis Association of America (MSAA) is pleased to recognize ten years of [...]
FDA approves MAVENCLAD® (Cladribine) tablets
- MAVENCLAD is the first oral MS treatment to provide two years of proven efficacy with a maximum of 20 days of treatment - MAVENCLAD's [...]
OHSU doctors part of ‘breakthrough’ research on treating multiple sclerosis
PORTLAND, Ore. (KATU) – They're calling it a potential game-changer. Doctors at Oregon Health and Science University are part of a new [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us





I have a question about

First

Last




Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM